Kashiv BioSciences to Be Acquired by Amneal Pharmaceuticals
MM Desk
25 April, 2026
Kashiv BioSciences has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals (NASDAQ:
Kashiv BioSciences has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals (NASDAQ:
Kashiv BioSciences, LLC has announced the appointment of Viet Nguyen as Chief Operating Officer and
Kashiv BioSciences has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals for
Kashiv BioSciences Private Limited has secured ₹648 crore in financing from the Union Bank of